drugset / Trial / NCT06905873
A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligo
RandomizedParallel-groupDouble-blindTreatment
Summary
A Randomized, Double-Blind, Placebo Controlled, Multi-center Study to Evaluate the Safety and Efficacy of FB102 in Patients with Non-Segmental Vitiligo.
Timeline
- Start
- 2025-03-25
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | FB102 | Unknown | — | Intravenous |